EUVIMEDEUVIMED entdecken
Crossref

Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration

Shuai Guo, Qi Sun, Xu Zhang, Song-Ye Li, Hong-Ye Liu, Gong-Hui Ge, Jing Wang, Xing-Yang Liu, Ben Xu, Ting-Ting Li, Xian-Feng Zhou, Yan-Ping Wang und 2 weitere

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Shuai Guo und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy/Key Laboratory of Research and Development of Small Molecule Targeted Antitumor Drugs, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Xanthine Oxidase, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Young Talents Program of China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In our previous study, we reported a series of N ‐(9,10‐anthraquinone‐2‐carbonyl) amino acid derivatives as novel inhibitors of xanthine oxidase (XO). Recognizing the suboptimal drug‐like properties associated with the anthraquinone moiety, we embarked on a nonanthraquinone medicinal chemistry exploration in the current investigation. Through systematic structure–activity relationship (SAR) studies, we identified a series of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives exhibiting excellent in vitro potency against XO. The optimized compound, 4‐isopentyloxy‐ N ‐(1 H ‐pyrazol‐3‐yl)‐3‐nitrobenzamide ( 6k ), demonstrated exceptional in vitro potency with an IC 50 value of 0.13 μM. Compound 6k showed favorable drug‐like characteristics with ligand efficiency (LE) and lipophilic ligand efficiency (LLE) values of 0.41 and 3.73, respectively. In comparison to the initial compound 1d , 6k exhibited a substantial 24‐fold improvement in IC 50 , along with a 1.6‐fold enhancement in LE and a 3.7‐fold increase in LLE. Molecular modeling studies provided insights into the strong interactions of 6k with critical amino acid residues within the active site. Furthermore, in vivo hypouricemic investigations convincingly demonstrated that 6k significantly reduced serum uric acid levels in rats. The MTT results revealed that compound 6k is nontoxic to healthy cells. The gastric and intestinal stability assay demonstrated that compound 6k exhibits good stability in the gastric and intestinal environments. In conclusion, compound 6k emerges as a promising lead compound, showcasing both exceptional in vitro potency and favorable drug‐like characteristics, thereby warranting further exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthine OxidaseEnzyme InhibitorsStructure-Activity RelationshipAnimalsRatsMolecular StructureMaleAnthraquinonesHumansDose-Response Relationship, DrugBenzamidesRats, Sprague-DawleyUric AcidDrug DiscoveryMolecular Docking Simulation

Stichwörter der Autor:innen

anthraquinonehyperuricemiastructural simplificationxanthine oxidase inhibitors

Substanzen

Xanthine OxidaseEnzyme InhibitorsAnthraquinonesBenzamidesUric Acid

Autor:innen und Institutionen

  • School of Pharmacy/Key Laboratory of Research and Development of Small Molecule Targeted Antitumor Drugs, China Medical University, Shenyang, China.

Förderung

  • National Natural Science Foundation of China
  • Young Talents Program of China Medical University

Zitieren

APA

Guo, S., Sun, Q., Zhang, X., Li, S. Y., Liu, H. Y., Ge, G. H., Wang, J., Liu, X. Y., Xu, B., Li, T. T., Zhou, X. F., Wang, Y. P., Meng, F. H., & Zhang, T. J. (2024). Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400137

Vancouver

Guo S, Sun Q, Zhang X, Li SY, Liu HY, Ge GH, et al. Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400137

BibTeX
@article{Guo2024,
  author = {Guo, Shuai and Sun, Qi and Zhang, Xu and Li, Song-Ye and Liu, Hong-Ye and Ge, Gong-Hui and Wang, Jing and Liu, Xing-Yang and Xu, Ben and Li, Ting-Ting and Zhou, Xian-Feng and Wang, Yan-Ping and Meng, Fan-Hao and Zhang, Ting-Jian},
  title = {Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400137}
}
Kostenlos starten →